Cancer Immunology Research,
Год журнала:
2022,
Номер
10(4), С. 384 - 402
Опубликована: Янв. 21, 2022
Abstract
Vaccination
has
been
a
game
changer
in
our
efforts
to
address
the
coronavirus
disease
2019
(COVID-19)
pandemic.
However,
might
still
represent
clinical
crisis
for
several
more
years,
part
because
of
inevitable
emergence
variants
capable
evading
preexisting
immunity.
Drugs
affecting
viral
spread
will
help
curtail
transmission,
but
therapeutics
are
needed
treat
severe
cases
requiring
hospitalization.
A
deep
analysis
evolving
immune
landscape
COVID-19
suggests
that
understanding
molecular
bases
distinct
stages
is
paramount
if
we
limit
burden
inflammation,
which
can
lead
death
frail
individuals,
according
age,
sex,
and
comorbidities.
Different
phases
be
defined
using
biomarkers
need
specific
therapeutic
approaches,
tailored
underlying
contexture.
Nature,
Год журнала:
2022,
Номер
611(7934), С. 139 - 147
Опубликована: Авг. 31, 2022
Abstract
Severe
SARS-CoV-2
infection
1
has
been
associated
with
highly
inflammatory
immune
activation
since
the
earliest
days
of
COVID-19
pandemic
2–5
.
More
recently,
these
responses
have
emergence
self-reactive
antibodies
pathologic
potential
6–10
,
although
their
origins
and
resolution
remained
unclear
11
Previously,
we
others
identified
extrafollicular
B
cell
activation,
a
pathway
formation
new
autoreactive
in
chronic
autoimmunity
12,13
as
dominant
feature
severe
critical
(refs.
14–18
).
Here,
using
single-cell
repertoire
analysis
patients
mild
disease,
identify
expansion
naive-derived,
low-mutation
IgG1
population
antibody-secreting
cells
(ASCs)
reflecting
features
low
selective
pressure.
These
correlate
progressive,
broad,
clinically
relevant
autoreactivity,
particularly
directed
against
nuclear
antigens
carbamylated
proteins,
emerging
10–15
after
onset
symptoms.
Detailed
low-selection
compartment
shows
high
frequency
clonotypes
specific
for
both
autoantigens,
including
pathogenic
autoantibodies
glomerular
basement
membrane.
We
further
contraction
this
on
recovery,
re-establishment
tolerance
standards
concomitant
loss
acute-derived
ASCs
irrespective
antigen
specificity.
However,
serological
autoreactivity
persists
subset
postacute
sequelae,
raising
important
questions
to
contribution
continuing
symptomology
recovery.
In
summary,
study
demonstrates
origins,
breadth
COVID-19,
implications
early
intervention
treatment
post-COVID
sequelae.
JAMA Network Open,
Год журнала:
2022,
Номер
5(3), С. e221313 - e221313
Опубликована: Март 9, 2022
Importance
The
immune
response
in
children
with
SARS-CoV-2
infection
is
not
well
understood.
Objective
To
compare
seroconversion
nonhospitalized
and
adults
mild
identify
factors
that
are
associated
seroconversion.
Design,
Setting,
Participants
This
household
cohort
study
of
collected
weekly
nasopharyngeal
throat
swabs
blood
samples
during
the
acute
(median,
7
days
for
12
[IQR,
4-13]
days)
convalescent
41
31-49]
periods
after
polymerase
chain
reaction
(PCR)
diagnosis
analysis.
Participants
were
recruited
at
Royal
Children's
Hospital,
Melbourne,
Australia,
from
May
10
to
October
28,
2020.
included
patients
who
had
a
SARS-CoV-2–positive
or
oropharyngeal
swab
specimen
using
PCR
Main
Outcomes
Measures
immunoglobulin
G
(IgG)
cellular
(T
cell
B
cell)
responses
adults.
Seroconversion
was
defined
by
seropositivity
all
3
(an
in-house
enzyme-linked
immunosorbent
assay
[ELISA]
2
commercial
assays:
S1/S2
IgG
antibody
ELISA)
serological
assays.
Results
Among
108
participants
findings,
57
(35
boys
[61.4%];
median
age,
4
2-10]
years)
51
(28
women
[54.9%];
37
34-45]
years).
Using
established
assays,
lower
proportion
compared
(20
54
[37.0%]
vs
32
42
[76.2%];P
<
.001).
result
viral
load,
which
similar
(mean
[SD]
cycle
threshold
[Ct]
value,
28.58
[6.83]
24.14
[8.47];P
=
.09).
In
addition,
age
sex
within
(median
2-14]
years
both
seropositive
seronegative
groups;
sex,
21
girls
[47.6%]
33
[30.3%])
ages,
40
34-39
years];
18
24
[75.0%]
14
men
[77.8%])
(P>
.05
comparisons
between
groups).
Symptomatic
3-fold
higher
levels
than
asymptomatic
227.5
133.7-521.6]
75.3
36.9-113.6]
IU/mL),
whereas
no
differences
observed
regardless
symptoms.
Moreover,
Conclusions
Relevance
findings
this
suggest
among
COVID-19,
may
be
less
likely
have
despite
loads.
finding
has
implications
future
protection
interpretation
serosurveys
involve
children.
Further
research
understand
why
development
symptoms
potentially
vaccine
clinical
scientific
importance.
Frontiers in Immunology,
Год журнала:
2022,
Номер
13
Опубликована: Июнь 10, 2022
Several
COVID-19
convalescents
suffer
from
the
post-acute
COVID-syndrome
(PACS)/long
COVID,
with
symptoms
that
include
fatigue,
dyspnea,
pulmonary
fibrosis,
cognitive
dysfunctions
or
even
stroke.
Given
scale
of
worldwide
infections,
long-term
recovery
and
integrative
health-care
in
nearest
future,
it
is
critical
to
understand
cellular
molecular
mechanisms
as
well
possible
predictors
longitudinal
post-COVID-19
responses
convalescent
individuals.
The
immune
system
T
cell
alterations
are
proposed
drivers
COVID
syndrome.
However,
despite
number
studies
on
COVID-19,
many
them
addressed
only
severe
short-term
responses.
Here,
we
performed
mild,
moderate
COVID-19-convalescent
patients,
at
two
time
points
(3
6
months
infection),
assess
dynamics
cells
landscape,
integrated
patients-reported
symptoms.
We
show
among
subsets
exhibit
different,
severity-
time-dependent
dynamics,
result
a
polarization
towards
an
exhausted/senescent
state
CD4+
CD8+
perturbances
Tregs.
In
particular,
high
proportion
CD57+
terminal
effector
cells,
together
significant
decrease
naïve
population,
augmented
granzyme
B
IFN-γ
production
unresolved
inflammation
after
infection.
Mild
showed
increased
naïve,
decreased
central
memory
Treg
subsets.
Patients
all
severity
groups
can
be
predisposed
long
symptoms,
fatigue
not
necessarily
related
dysfunctions,
was
found
convalescents.
conclusion,
functional
remodeling
could
seen
two-step
process,
leading
distinct
states
Our
data
imply
attenuation
blocking
might
influence
post-COVID
either
search
for
any
treatment
prevent
PACS
further
complications
mandatory
patients
SARS-CoV-2
infection,
those
suffering
COVID-19.
Cellular and Molecular Immunology,
Год журнала:
2024,
Номер
21(2), С. 119 - 133
Опубликована: Янв. 18, 2024
The
COVID-19
pandemic,
which
was
caused
by
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
has
become
a
worldwide
health
crisis
due
to
its
transmissibility.
SARS-CoV-2
infection
results
in
illness
and
can
lead
significant
complications
affected
individuals.
These
encompass
symptoms
such
as
coughing,
distress,
fever,
infectious
shock,
distress
(ARDS),
even
multiple-organ
failure.
Animal
models
serve
crucial
tools
for
investigating
pathogenic
mechanisms,
immune
responses,
escape
antiviral
drug
development,
vaccines
against
SARS-CoV-2.
Currently,
various
animal
infection,
nonhuman
primates
(NHPs),
ferrets,
hamsters,
many
different
mouse
models,
have
been
developed.
Each
model
possesses
distinctive
features
applications.
In
this
review,
we
elucidate
the
response
elicited
patients
provide
an
overview
of
characteristics
mainly
used
well
corresponding
responses
applications
these
models.
A
comparative
analysis
transcriptomic
alterations
lungs
from
revealed
that
K18-hACE2
mouse-adapted
virus
exhibited
highest
similarity
with
deceased
patients.
Finally,
highlighted
current
gaps
related
research
between
studies
clinical
investigations,
underscoring
lingering
scientific
questions
demand
further
clarification.
Journal of Clinical Immunology,
Год журнала:
2021,
Номер
41(8), С. 1709 - 1722
Опубликована: Окт. 20, 2021
Abstract
Background
Data
on
immune
responses
to
SARS-CoV-2
in
patients
with
Primary
Antibody
Deficiencies
(PAD)
are
limited
infected
and
heterogeneous
cohorts
after
immunization.
Methods
Forty-one
Common
Variable
Immune
(CVID),
six
X-linked
Agammaglobulinemia
(XLA),
28
healthy
age-matched
controls
(HD)
were
analyzed
for
anti-Spike
anti-receptor
binding
domain
(RBD)
antibody
production,
generation
of
Spike-specific
memory
B-cells,
T-cells
before
vaccination
one
week
the
second
dose
BNT162b2
vaccine.
Results
The
vaccine
induced
IgG
IgA
all
HD
20%
naive
CVID
patients.
Anti-Spike
detectable
4
out
7
previously
boosted
seven
by
subsequent
immunization
raising
higher
levels
than
naïve
infection.
While
generated
RBD-specific
atypical
while
B-cells
undetectable
patients,
indicating
incapability
generate
this
new
specificity.
Specific
T-cell
evident
defective
30%
CVID.
All
but
patient
XLA
responded
specific
only.
Conclusion
In
PAD
early
occurred,
possibly
extra-follicular
or
incomplete
germinal
center
reactions.
If
these
might
result
a
partial
protection
from
infection
reinfection
is
now
unknown.
Our
data
suggests
that
more
effectively
primes
response
alone,
suggesting
need
third
not
infected.
Frontiers in Immunology,
Год журнала:
2021,
Номер
12
Опубликована: Окт. 5, 2021
Aging
is
considered
to
be
an
important
risk
factor
for
several
inflammatory
diseases.
B
cells
play
a
major
role
in
chronic
diseases
by
antibody
secretion,
antigen
presentation
and
T
cell
regulation.
Different
subsets
have
been
implicated
infections
multiple
autoimmune
Since
aging
decreases
numbers,
affects
impairs
responses,
the
aged
expected
impacts
on
development
progression
of
these
In
this
review,
we
summarize
health
disease
settings,
such
as
atherosclerotic
disease.
Furthermore,
provide
overview
age-related
changes
function
with
respect
their
impact
Frontiers in Immunology,
Год журнала:
2023,
Номер
14
Опубликована: Янв. 30, 2023
The
current
coronavirus
pandemic
(COVID-19),
caused
by
SARS-CoV-2,
has
had
devastating
effects
on
the
global
health
and
economic
system.
cellular
molecular
mediators
of
both
innate
adaptive
immune
systems
are
critical
in
controlling
SARS-CoV-2
infections.
However,
dysregulated
inflammatory
responses
imbalanced
immunity
may
contribute
to
tissue
destruction
pathogenesis
disease.
Important
mechanisms
severe
forms
COVID-19
include
overproduction
cytokines,
impairment
type
I
IFN
response,
overactivation
neutrophils
macrophages,
decreased
frequencies
DC
cells,
NK
cells
ILCs,
complement
activation,
lymphopenia,
Th1
Treg
hypoactivation,
Th2
Th17
hyperactivation,
as
well
clonal
diversity
B
lymphocyte
function.
Given
relationship
between
disease
severity
an
system,
scientists
have
been
led
manipulate
system
a
therapeutic
approach.
For
example,
anti-cytokine,
cell,
IVIG
therapies
received
attention
treatment
COVID-19.
In
this
review,
role
development
progression
is
discussed,
focusing
aspects
mild
vs.
Moreover,
some
immune-
based
approaches
being
investigated.
Understanding
key
processes
involved
developing
agents
optimizing
related
strategies.
Vaccines,
Год журнала:
2023,
Номер
11(2), С. 408 - 408
Опубликована: Фев. 10, 2023
The
coronavirus
2019
(COVID-19)
pandemic
was
caused
by
a
positive
sense
single-stranded
RNA
(ssRNA)
severe
acute
respiratory
syndrome
2
(SARS-CoV-2).
However,
other
human
coronaviruses
(hCoVs)
exist.
Historical
pandemics
include
smallpox
and
influenza,
with
efficacious
therapeutics
utilized
to
reduce
overall
disease
burden
through
effectively
targeting
competent
host
immune
system
response.
is
composed
of
primary/secondary
lymphoid
structures
initially
eight
types
cell
types,
many
subtypes,
traversing
membranes
utilizing
signaling
cascades
that
contribute
towards
clearance
pathogenic
proteins.
Other
proteins
discussed
cluster
differentiation
(CD)
markers,
major
histocompatibility
complexes
(MHC),
pleiotropic
interleukins
(IL),
chemokines
(CXC).
historical
concepts
immunity
are
the
innate
adaptive
systems.
represented
T
cells,
B
antibodies.
macrophages,
neutrophils,
dendritic
complement
system.
viruses
can
affect
regulate
cycle
progression
for
example,
in
cancers
papillomavirus
(HPV:
cervical
carcinoma),
Epstein-Barr
virus
(EBV:
lymphoma),
Hepatitis
C
(HB/HC:
hepatocellular
carcinoma)
Leukemia
Virus-1
(T
leukemia).
Bacterial
infections
also
increase
risk
developing
cancer
(e.g.,
EMBO Molecular Medicine,
Год журнала:
2023,
Номер
15(9)
Опубликована: Июнь 5, 2023
Abstract
Most
mature
B
cells
can
be
divided
into
four
subtypes
based
on
the
expression
of
surface
markers
IgD
and
CD27:
+
CD27
−
naïve
cells,
unswitched
memory
switched
double‐negative
(DN)
cells.
Despite
their
small
population
size
in
normal
peripheral
blood,
DN
play
integral
roles
various
diseases.
For
example,
they
generate
autoimmunity
autoimmune
conditions,
while
these
may
both
antipathogenic
responses
COVID‐19,
or
act
a
purely
capacity
malaria.
Recently,
have
been
identified
nasopharyngeal
carcinoma
non‐small‐cell
lung
cancers,
where
an
immunosuppressive
role.
The
distinct
functions
that
different
diseases
suggest
are
heterogeneous
B‐cell
population.
Therefore,
further
study
mechanisms
underlying
involvement
is
essential
for
understanding
pathogenesis
development
therapeutic
strategies.
Further
research
thus
warranted
to
characterize
detail.